St. Luke’s University Health Network (SLUHN) heart specialists are the first in the Lehigh Valley region to employ advanced ...

Ord Minnett is approaching investors with another capital raising for Echo IQ, a $200 million market-capped stock focused on ...

A trend toward higher mortality in women with PPM who received a self-expanding valves deserves more scrutiny, though.

A pioneering heart centre at Basildon Hospital is celebrating a major milestone after carrying out its 1,000th "life-changing procedure". The Essex Cardiothoracic Centre (CTC), based at Basildon ...

The procedure is used to treat aortic stenosis, a condition where the valve that controls blood flow out of the heart becomes narrowed. The procedure is minimally invasive and helps patients avoid ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

Aortic stenosis is a narrowing of the aortic valve opening, which restricts blood flow from the heart to the rest of the body ...

platform for the treatment of patients with asymptomatic severe aortic stenosis (AS), expanding its use to a broader population. Marking a first approval for a TAVR system’s use in asymptomatic ...

"There is an urgent need to change practice and TAVR guidelines for the treatment of aortic stenosis patients, which currently recommend ‘watchful waiting’ until symptoms develop," said ...